Nobiletin ameliorates streptozotocin-cadmium-induced diabetic nephropathy via NF-κB signalling pathway in rats

References

• Ahmed, O.M., et al., 2019. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats. PloS one, 14 (9), e0214349.
   PubMed Web of Science ®Google Scholar
• Almeer, R.S., et al., 2019. Royal jelly attenuates cadmium-induced nephrotoxicity in male mice. Scientific reports, 9 (1), 5812–5825.
   PubMedGoogle Scholar
• American Diabetes Association 2009. Diagnosis and classification of diabetes mellitus. Diabetes care, 32, S62–S67.
   PubMed Web of Science ®Google Scholar
• Calabrese, V., et al., 2021. Oxidative stress and cellular stress response in diabetic nephropathy. Frontiers in physiology, 12, 662666.
   PubMedGoogle Scholar
• Chan, H.M., et al., 1993. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicology and applied pharmacology, 123 (1), 89–96.
   PubMed Web of Science ®Google Scholar
• Chen, J., Montanari, A.M., and Widmer, W.W., 1997. Two new polymethoxylated flavones, a class of compounds with potential anticancer activity, isolated from cold pressed dancy tangerine peel oil solids. Journal of agricultural and food chemistry, 45 (2), 364–368.
   Web of Science ®Google Scholar
• Choudhury, H., et al., 2018. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. Journal of traditional and complementary medicine, 8 (3), 361–376.
   PubMedGoogle Scholar
• Dabla, P.K., 2010. Renal function in diabetic nephropathy. World journal of diabetes, 1 (2), 48–56.
   PubMedGoogle Scholar
• Fakhruddin, S., Alanazi, W., and Jackson, K.E., 2017. Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury. Journal of diabetes research, 2017, 8379327.
   PubMed Web of Science ®Google Scholar
• Ferraro, P.M., et al., 2010. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC public health, 10, 304.
   PubMed Web of Science ®Google Scholar
• Ferreira, C.A., et al., 2018. Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano research, 11 (10), 4955–4984.
   PubMed Web of Science ®Google Scholar
• Fraga, C.G., Leibovitz, B.E., and Tappel, A.L., 1988. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free radical biology & medicine, 4 (3), 155–161.
   PubMed Web of Science ®Google Scholar
• Friederich-Persson, M., et al., 2013. Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension, 62 (5), 914–919.
   PubMed Web of Science ®Google Scholar
• Gandhi, G.R., and Sasikumar, P., 2012. Antidiabetic effect of Merremia emarginata Burm. F. in streptozotocin induced diabetic rats. Asian Pacific journal of tropical biomedicine, 2 (4), 281–286.
   PubMedGoogle Scholar
• Gross, J.L., et al., 2005. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes care, 28 (1), 164–176.
   PubMed Web of Science ®Google Scholar
• Heerspink, H.J.L., et al.,; for the DAPA-CKD Investigators 2020. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Nephrology dialysis transplantation, 35 (2), 274–282.,
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein, M., et al., 2014. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. Journal of lipid research, 55 (3), 561–572.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox, J., and Coupland, C., 2016. Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care. BMJ, 352, 24.
   Google Scholar
• Jha, V., and Modi, G., 2017. Uncovering the rising kidney failure deaths in India. The lancet global health, 5 (1), e14–e15.
   PubMed Web of Science ®Google Scholar
• Jiang, Z.-Y., Hunt, J.V., and Wolff, S.P., 1992. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Analytical biochemistry, 202 (2), 384–389.
   PubMed Web of Science ®Google Scholar
• Jin, T., et al., 1999. The susceptibility to nephrotoxicity of streptozotocin-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology, 142 (1), 69–75.
   PubMed Web of Science ®Google Scholar
• Kakkar, P., Das, B., and Viswanathan, P., 1984. A modified spectrophotometric assay of superoxide dismutase. IJBB, 21, 130–132.
   Google Scholar
• Kalaiarasi, P., and Pugalendi, K.V., 2009. Antihyperglycemic effect of 18β-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats. European journal of pharmacology, 606 (1–3), 269–273.
   PubMed Web of Science ®Google Scholar
• Kandasamy, N., and Ashokkumar, N., 2014a. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy. European journal of pharmacology, 743, 53–62.
   PubMed Web of Science ®Google Scholar
• Kandasamy, N., and Ashokkumar, N., 2014b. Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats. Toxicology and applied pharmacology, 279 (2), 173–185.
   PubMed Web of Science ®Google Scholar
• Lee, Y.-S., et al., 2010. Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochemical pharmacology, 79 (11), 1674–1683.
   PubMed Web of Science ®Google Scholar
• Lin, N., et al., 2003. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochemical pharmacology, 65 (12), 2065–2071.
   PubMed Web of Science ®Google Scholar
• Lin, Y., et al., 2011. Molecular structures of citrus flavonoids determine their effects on lipid metabolism in HepG2 cells by primarily suppressing apoB secretion. Journal of agricultural and food chemistry, 59 (9), 4496–4503.
   PubMed Web of Science ®Google Scholar
• Miyata, Y., et al., 2008. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochemical and biophysical research communications, 366 (1), 168–173.
   PubMed Web of Science ®Google Scholar
• Mulvihill, E.E., et al., 2011. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. Diabetes, 60 (5), 1446–1457.
   PubMed Web of Science ®Google Scholar
• Nair, A.R., et al., 2013. Cadmium-induced pathologies: where is the oxidative balance lost (or not)? International journal of molecular sciences, 14 (3), 6116–6143.
   PubMed Web of Science ®Google Scholar
• Nakajima, A., and Ohizumi, Y., 2019. Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer's disease and Parkinson's disease. International journal of molecular sciences, 20 (14), 3380.
   PubMed Web of Science ®Google Scholar
• Nguyen-Ngo, C., et al., 2020. Nobiletin exerts anti-diabetic and anti-inflammatory effects in an in vitro human model and in vivo murine model of gestational diabetes. Clinical science, 134 (6), 571–592.
   PubMed Web of Science ®Google Scholar
• Nogata, Y., et al., 2006. Flavonoid composition of fruit tissues of citrus species. Bioscience biotechnology and biochemistry, 70 (1), 178–192.
   PubMed Web of Science ®Google Scholar
• Orr, S.E., and Bridges, C.C., 2017. Chronic kidney disease and exposure to nephrotoxic metals. International journal of molecular sciences, 18, 1039.
   PubMed Web of Science ®Google Scholar
• Parkar, N., Bhatt, L., and Addepalli, V., 2016. Efficacy of nobiletin, a citrus flavonoid, in the treatment of the cardiovascular dysfunction of diabetes in rats. Food & function, 7 (7), 3121–3129.
   PubMed Web of Science ®Google Scholar
• Perkovic, V., et al., 2019. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380 (24), 2295–2306.
   PubMed Web of Science ®Google Scholar
• Prophet, E. B., 1992. Laboratory methods in histotechnology: Amer Registry of Pathology. Washington, D.C. Armed Forces Institute of Pathology (U.S.).
   Google Scholar
• Ramachandran, V., and Saravanan, R., 2013. Efficacy of asiatic acid, a pentacyclic triterpene on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-induced diabetic rats. Phytomedicine, 20 (3-4), 230–236.
   PubMed Web of Science ®Google Scholar
• Rotruck, J.T., et al., 1973. Selenium: biochemical role as a component of glutathione peroxidase. Science, 179 (4073), 588–590.
   PubMed Web of Science ®Google Scholar
• Saleh, J., 2015. Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors? World journal of cardiology, 7 (8), 449–453.
   PubMed Web of Science ®Google Scholar
• Sherwani, S.I., et al., 2016. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights, 11, 95–104. BMI-S38440.
   PubMed Web of Science ®Google Scholar
• Shukla, R., Banerjee, S., and Tripathi, Y.B., 2018. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats. BMC complementary and alternative medicine, 18 (1), 111–156.
   PubMedGoogle Scholar
• Sinha, A.K., 1972. Colorimetric assay of catalase. Analytical biochemistry, 47 (2), 389–394.
   PubMed Web of Science ®Google Scholar
• Surichan, S., et al., 2018. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food and chemical toxicology, 113, 228–235.
   PubMed Web of Science ®Google Scholar
• Tomita, T., 2016. Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosnian journal of basic medical sciences, 16 (3), 162–179.
   PubMed Web of Science ®Google Scholar
• Tonneijck, L., et al., 2017. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. Journal of the American society of nephrology, 28 (4), 1023–1039.
   PubMed Web of Science ®Google Scholar
• Volarevic, V., et al., 2019. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of biomedical science, 26 (1), 14–25.
   PubMedGoogle Scholar
• Wang, M., et al., 2018. Antioxidant protection of nobiletin, 5-demethylnobiletin, tangeretin, and 5-demethyltangeretin from citrus peel in Saccharomyces cerevisiae. Journal of agricultural and food chemistry, 66 (12), 3155–3160.
   PubMed Web of Science ®Google Scholar
• Wu, C., et al., 2017. Histological changes, lipid metabolism and oxidative stress in the liver of Bufo gargarizans exposed to cadmium concentrations. Chemosphere, 179, 337–346.
   PubMed Web of Science ®Google Scholar
• Zhang, X.-X., Kong, J., and Yun, K., 2020. Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies. Journal of diabetes research, 2020, 1–11.
   Web of Science ®Google Scholar